Drug Profile
Estradiol/nomegestrol continuous
Alternative Names: E2/Nomac continuous; EMM 220066; Nomac/E2 continuousLatest Information Update: 08 Feb 2018
Price :
$50
*
At a glance
- Originator Theramex SAM
- Class Estradiol congeners; Estrenes; Hormonal contraceptives; Hormonal replacements; Pregnadienes; Progesterone congeners; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 01 Feb 2018 Teva Women's Health was sold by Teva Pharmaceuticals to CVC Capital Partners, to create an international pharmaceutical company dedicated to Women’s Health named Theramex
- 02 Jun 2006 Discontinued - Phase-III for Menopausal syndrome in Europe (PO)
- 08 Jan 2002 Discontinued-II for Postmenopausal osteoporosis in Europe (PO)